You are in the accessibility menu

Please use this identifier to cite or link to this item: http://acervodigital.unesp.br/handle/11449/129846
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSato, Mariana Rillo-
dc.contributor.authorSilva, Patricia Bento da-
dc.contributor.authorSouza, Rodrigo Alves de-
dc.contributor.authorSantos, Karen Cristina dos-
dc.contributor.authorChorilli, Marlus-
dc.date.accessioned2015-10-22T07:20:11Z-
dc.date.accessioned2016-10-25T21:16:37Z-
dc.date.available2015-10-22T07:20:11Z-
dc.date.available2016-10-25T21:16:37Z-
dc.date.issued2015-01-01-
dc.identifierhttp://www.ncbi.nlm.nih.gov/pubmed/25579344-
dc.identifier.citationCurrent Topics In Medicinal Chemistry. Sharjah: Bentham Science Publ Ltd, v. 15, n. 4, p. 287-297, 2015.-
dc.identifier.issn1568-0266-
dc.identifier.urihttp://hdl.handle.net/11449/129846-
dc.identifier.urihttp://acervodigital.unesp.br/handle/11449/129846-
dc.description.abstractCoordination compounds are substances in which a central metal atom is bonded to nonmetal atoms, or groups of atoms, called ligands. Examples include vitamin B-12, hemoglobin, chlorophyll, dyes and pigments, as well as catalysts used in organic synthesis. Coordination compounds have received much attention in recent years. This interest was prompted by the discovery that several coordination compounds exhibit activity against bacteria, fungi and cancer. Some coordination compounds are not in clinical use, because of poor water solubility. Because they are unable to cross the lipid membranes of cells, bioavailability and efficacy are low. Some researchers have applied nanotechnology to coordination compounds, hoping to reduce the number of doses required and the severity of side effects, and also to improve biological activity. Nanotechnology can deliver active components in sufficient concentrations throughout treatment, guiding it to the desired location of action; conventional treatments do not meet these requirements. In this study we review some drug delivery systems based on nanotechnology, such as microemulsions (MEs), cyclodextrin (CD), polymeric nanoparticles (PN), solid lipid nanoparticles (SLNs), nanostructured lipid carriers (NLCs), magnetic and gold nanoparticles (MNPs / AuNPs) and liquid crystalline systems (LC), and coordination compounds.en
dc.description.sponsorshipFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)-
dc.description.sponsorshipConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)-
dc.description.sponsorshipFCFAr-
dc.description.sponsorshipPADC-
dc.format.extent287-297-
dc.language.isoeng-
dc.publisherBentham Science Publ Ltd-
dc.sourceWeb of Science-
dc.subjectBiological activityen
dc.subjectCoordination compounden
dc.subjectDrug delivery systemsen
dc.subjectMetallic complexen
dc.subjectNanosystemsen
dc.subjectNanotechnologyen
dc.titleRecent advances in nanoparticle carriers for coordination complexesen
dc.typeoutro-
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)-
dc.description.affiliationUnespSchool of Pharmaceutical Sciences, São Paulo State University, Araraquara, Brazil-
dc.description.affiliationUnespSao Paulo State University, Inst Chemical, Araraquara, Brazil-
dc.identifier.doihttp://dx.doi.org/10.2174/1568026615666150108145614#sthash.9dA3x5hB.dpuf-
dc.identifier.wosWOS:000351013200004-
dc.rights.accessRightsAcesso restrito-
dc.relation.ispartofCurrent Topics In Medicinal Chemistry-
Appears in Collections:Artigos, TCCs, Teses e Dissertações da Unesp

There are no files associated with this item.
 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.